# Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients

> **NCT01169753** · NA · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 1 (actual)

## Conditions studied

- Chronic Myeloid Leukemia

## Interventions

- **DRUG:** Placebo
- **DRUG:** Armodafinil

## Key facts

- **NCT ID:** NCT01169753
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-05
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Slow Enrollment
- **Last updated:** 2015-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01169753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01169753, "Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01169753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*